BMY Related Analyst EPS View
-
UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
-
Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
-
ICON (ICLR) on Watch as Bristol-Myers Squibb (BMY) Adds New Lab Provider
-
NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
-
UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech
-
Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
-
Nomura Securities Reiterates a 'Reduce' on AstraZeneca (AZN); Overpayment Risk in Deal with Bristol Myers (BMY)
Back to BMY Stock Lookup
